Dysregulation of CCAT116, UCA117, and MEG318 has been previously linked to CRC, while dysregulation of LINC0097419 and TRPM2-AS20 have been reported in hepatocellular carcinoma and prostate cancer, respectively. Here, TRPM2 is linked to colorectal carcinoma.